Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

Scientific Reports(2022)10.1038/s41598-022-05949-7Source: DataRank Database

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer is a research paper published in Scientific Reports (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 3.53)OA: goldTopics (105)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Hariprasad Thangavel ORCID,Noor Mazin Abdulkareem ORCID,Suhas Vasaikar ORCID,Carmine De Angelis ORCID,Leon Bae

Live enrichment

PubMed:35121782 PMC:PMC8817007 OpenAlex:https://openalex.org/W4210471921

Department of Defense BCRP

Grant: W81XWH-14-1-0341

Department of Defense BCRP

Grant: W81XWH-14-1-0340

Breast Cancer Research Foundation

Grant: BCRF-18-145

Breast Cancer Research Foundation

Grant: BCRF-19-145

NIH

Grant: CA125123

NIH

Grant: P50 CA058183

NIH

Grant: CA186784-01

NCI NIH HHS

Grant: P50 CA186784

National Institutes of Health

Grant: 3P50CA058183-08S5

DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER

National Institutes of Health

Grant: 3P30CA125123-09S3

Baylor College of Medicine Cancer Center

National Institutes of Health

Grant: 3P50CA186784-10S1

Translational Research in Breast Cancer

FWCI

3.53

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-022-05949-7.pdf

publisherhttps://www.nature.com/articles/s41598-022-05949-7.pdf

publisherhttps://www.nature.com/articles/s41598-022-05949-7

journalhttps://doi.org/10.1038/s41598-022-05949-7

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35121782

Fields of Study

Estrogen and related hormone effectsReceptor Mechanisms and SignalingUbiquitin and proteasome pathways0301 basic medicine03 medical and health sciences0303 health sciencesAnimalsAntineoplastic Agents, HormonalBreast NeoplasmsCell Line, TumorCell ProliferationDrug Resistance, NeoplasmEndocrine Gland NeoplasmsEstradiolEstrogen Receptor alphaEstrogensFemaleFulvestrantGene Expression Regulation, NeoplasticHeterograftsHumansMiceNeoplasm Recurrence, LocalErb-b2 Receptor Tyrosine KinasesReceptors, G-Protein-CoupledReceptors, Neuropeptide YTamoxifen

MeSH Terms

FulvestrantAnimalsBreast NeoplasmsEndocrine Gland NeoplasmsEstradiolEstrogensFemaleHumansNeoplasm Recurrence, LocalTamoxifenGene Expression Regulation, NeoplasticReceptors, Neuropeptide YReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesAntineoplastic Agents, HormonalDrug Resistance, NeoplasmReceptors, G-Protein-CoupledCell Line, TumorEstrogen Receptor alphaCell ProliferationMiceHeterografts

Keywords

Endocrine systemBreast cancerInhibitory postsynaptic potentialSensitivity (control systems)OncologyInternal medicineAction (physics)EndocrinologyMedicineCancerCancer researchBioinformaticsBiologyHormonePhysicsAntineoplastic Agents, HormonalScienceDrug ResistanceAntineoplastic AgentsBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesArticleCell LineReceptors, G-Protein-CoupledG-Protein-CoupledMiceErbB-2Cell Line, TumorReceptorsEndocrine Gland NeoplasmsAnimals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Endocrine Gland Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Neoplasm Recurrence, Local; Receptor, ErbB-2; Receptors, G-Protein-Coupled; Receptors, Neuropeptide Y; TamoxifenAnimalsHumansNeuropeptide YFulvestrantCell ProliferationNeoplasticTumorHormonalEstradiolQREstrogen Receptor alphaEstrogensReceptors, Neuropeptide YGene Expression Regulation, NeoplasticTamoxifenNeoplasm RecurrenceGene Expression RegulationLocalDrug Resistance, NeoplasmNeoplasmHeterograftsFemaleNeoplasm Recurrence, LocalReceptor

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being